Every 424B that Ionq Inc (IONQ) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IONQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IONQ filings page.
IonQ to acquire SkyWater for $15.00 cash plus IonQ stock per share. Under the Merger Agreement dated January 25, 2026, SkyWater will merge into IonQ subsidiaries in a two-step transaction. Each SkyWater share will receive $15.00 in cash plus IonQ common stock determined by an exchange ratio tied to IonQ’s 20-day VWAP (Exchange Ratio: 0.5265 if VWAP ≤ $37.99, 0.3326 if VWAP ≥ $60.13, otherwise $20 divided by the IonQ Trading Price). The SkyWater Board unanimously recommends approval and SkyWater will hold a virtual special meeting on May 8, 2026 (record date: March 26, 2026). Completion is subject to stockholder approval, HSR clearance, NYSE listing of issued IonQ shares and effectiveness of the Form S-4 registration statement.
IonQ, Inc. files a prospectus supplement to register up to 2,562,642 shares of its common stock for resale by a selling stockholder. The prospectus supplement states the company will not receive any proceeds from sales by the selling stockholder and that sales may occur on exchanges, OTC, privately, or by other permitted methods.
Shares outstanding were 366,640,756 as of February 18, 2026. The selling stockholder identified is The Chancellor, Masters, and Scholars of the University of Cambridge, which may sell any, all or none of the registered shares.
IonQ, Inc. filed a supplement to its prospectus supplement to correct the Calculation of Registration Fee table by adding 280,958 shares of common stock to the Amount Registered. The supplement states this amendment only corrects the fee table and that no other changes were made to the prospectus supplement or accompanying prospectus.
IonQ, Inc. registers for resale up to 5,127,459 shares of its common stock by selling stockholders, with the company receiving no proceeds from sales under this prospectus supplement dated February 27, 2026. The resale may occur on the NYSE, over-the-counter markets, in privately negotiated transactions or by other permitted methods, at fixed, prevailing or negotiated prices.
Context: shares outstanding were 366,640,756 as of February 18, 2026, and the last reported NYSE sale price was $31.62 on February 24, 2026. The selling stockholders include named holders with per-holder amounts such as Marlu R. Oswald: 1,160,150 and Southern Skies, LLC: 844,348, and other holders collectively covering the remaining registered shares.
IonQ, Inc. is offering units consisting of common stock or pre-funded warrants each paired with two Series B warrants, with aggregate gross proceeds shown at approximately $2,000,001,699.46 for the primary tranche and an additional $20,000,022.00 attributable to pre-funded components and underwriting items. The offering includes 16,500,000 shares, 43,010,800 Series B Warrants exercisable at $155.00 per share, and 5,005,400 Pre-funded Warrants exercisable at $0.0001 per share, together enabling up to 48,016,200 shares upon exercise.
The company intends to use net proceeds for working capital, general corporate purposes and possibly strategic acquisitions or partnerships. Underwriting discounts total $20,000,022.00 with a per-share/pre-funded warrant fee of $0.93. Lock-up agreements run for 60 days with specified exceptions. The prospectus discusses warrant anti-dilution adjustments, treatment in a Fundamental Transaction, and detailed U.S. and non-U.S. tax considerations for holders.
IonQ is offering a package of common stock, Pre-funded Warrants and Series B Warrants packaged as units at a purchase price of $93.00 per unit. The offering includes 16,500,000 shares of common stock, 43,010,800 Series B Warrants, and 5,005,400 Pre-funded Warrants, with a total of 48,016,200 shares issuable upon exercise of the Warrants. Each Series B Warrant is exercisable for one share at an exercise price of $155.00; each Pre-funded Warrant is exercisable for one share at an exercise price of $0.0001 and may be exercised on or prior to seven years after issuance.
The prospectus shows underwriting discounts of $0.93 per share/Pre-funded Warrant and discloses intended uses of proceeds for working capital, corporate purposes and possible strategic acquisitions or partnerships. Certain insiders are subject to a 60-day lock-up with customary exceptions. Tax treatment, potential adjustments on corporate events, and anti-dilution/Fundamental Transaction provisions for the Warrants are described.